Advancing preclinical research with high-standard solutions for toxicology, mechanism-of-action studies, and disease modeling using diverse stem cell-derived tissue platforms.
Execution of GLP (Good Laboratory Practices) Quality Preclinical Tests for the Pharmaceutical and Cosmetic Industries
Testing Systems Created from Human Induced Pluripotent Stem Cells to Support Biotechnological Developments and Research Purposes
Our team consists of internationally recognized, highly skilled professionals.
Our mission is to accelerate pharmaceutical and cosmetic innovation by providing human stem cell-based 3D models that replace animal testing and deliver more predictive results.
Global regulators (FDA, EMA and China’s NMPA) are phasing out animal testing and now endorse advanced alternatives such as stem cell–based models and organoids, accelerating adoption of human-relevant models.
The development of the technologies we employ is carried out by internationally recognized experts and professionals in the fields of stem cell research and drug development.
InnoCell provides advanced stem cell and human 3D model technologies for the creation of GLP-compliant tissue platforms. Designed for pharmaceutical and cosmetic applications, our solutions enhance precision, safety, and translational relevance.
Quality. Reliability. Expertise.
Valami bemutatkozó szöveg hosszasan. Valami bemutatkozó szöveg hosszasan. Valami bemutatkozó szöveg hosszasan. Valami bemutatkozó szöveg hosszasan. Valami bemutatkozó szöveg hosszasan. Valami bemutatkozó szöveg hosszasan. Valami bemutatkozó szöveg hosszasan.Valami bemutatkozó szöveg hosszasan.Valami bemutatkozó szöveg hosszasan.Valami bemutatkozó szöveg hosszasan.Valami bemutatkozó szöveg hosszasan.Valami bemutatkozó szöveg hosszasan.
Reprogramming patient-derived somatic cells into high-quality, integration-free iPSC lines, using clinically validated, footprint-free methods — ideal for research, disease modeling, and drug discovery workflows.
We generate 3D spheroid and organoid models from both healthy and patient-derived iPSCs. These models offer valuable tools for academic research and industrial applications in disease modeling and therapeutic development.
Human iPSC-derived 3D models offer physiologically relevant platforms to assess compound safety and efficacy. Our assays support target validation, mechanism-of-action studies, and preclinical development with translational data.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
At InnoCell, we prioritize supporting large-scale advancements in an ethical and sustainable manner. The guidelines from the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) increasingly advocate for the use of human cell-based test systems in preclinical drug development and toxicology studies to reduce animal testing
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
With the support of our diagnostics capabilities to deliver drug trials that are both reliable and rigorous.
We process more than 3 million patient specimens per week and help medical professionals and patients make important health decisions, by identifying patterns and even individuals who might benefit from enrollment in specific drug trials.
With a belief that knowledge is power, we connect our patients directly with their results so they have valuable health information when they need it most, care about our people and are committed to excellence in the work we do for people to grow and strive for excellence.
At every step in the testing process, from collection to reporting, we provide caring, efficient, reliable and high-quality services. As trusted partner supporting patients, healthcare providers and entire provincial healthcare systems, we are harnessing our medical expertise to build the best test offering while investing in technology.
We will work with you to develop individualised care plans, including management of chronic diseases. If we cannot assist, we can provide referrals or advice about the type of practitioner you require to treat all enquiries sensitively.
With any financial product that you buy, it is important that you know you are getting the best advice from a reputable company as often
With any financial product that you buy, it is important that you know you are getting the best advice from a reputable company as often
InnoCell provides advanced stem cell and human 3D model technologies for the creation of GLP-compliant tissue platforms. Designed for pharmaceutical and cosmetic applications, our solutions enhance precision, safety, and translational relevance.
Valami bemutatkozó szöveg hosszasan. Valami bemutatkozó szöveg hosszasan. Valami bemutatkozó szöveg hosszasan. Valami bemutatkozó szöveg hosszasan. Valami bemutatkozó szöveg hosszasan. Valami bemutatkozó szöveg hosszasan. Valami bemutatkozó szöveg hosszasan.Valami bemutatkozó szöveg hosszasan.Valami bemutatkozó szöveg hosszasan.Valami bemutatkozó szöveg hosszasan.Valami bemutatkozó szöveg hosszasan.Valami bemutatkozó szöveg hosszasan.
Quality. Reliability. Expertise.